(Total Views: 49)
Posted On: 09/23/2025 1:15:09 PM
Post# of 99506
Growth stock with breakout potential near-term (NASDAQ: ONMD)
New growth report with near-term breakout potential.
OneMedNet Corp (NASDAQ: ONMD)
Why This Could Be a Breakout Stock
Low Float – With only 25.6M shares tradeable, modest buying interest can move the stock significantly.
High Insider Ownership – At 46.7% insider ownership, management is heavily aligned with shareholder interests.
Massive Market Tailwinds – Healthcare AI, clinical trials, digital health, and regulatory trends all converge here.
Recurring Revenue Model – Enterprise data licensing provides predictability and scalability.
Positive Momentum – Trading above both its 50-day ($0.52) and 200-day ($0.72) moving averages, suggesting technical strength.
Recent Insider Buying.
When combined, these factors position ONMD as a potential “under-the-radar” healthcare data play with asymmetric upside.
Chart: Trading above moving averages, looking for a golden cross in the near-term.
Take a minute to view this must-read full report and disclosures on ONMD: https://bestgrowthstocks.com/onemednet-nasdaq...ealthcare/
It’s not biotech. It’s not big pharma. It’s the infrastructure behind both—and that could make all the difference!
New growth report with near-term breakout potential.
OneMedNet Corp (NASDAQ: ONMD)
Why This Could Be a Breakout Stock
Low Float – With only 25.6M shares tradeable, modest buying interest can move the stock significantly.
High Insider Ownership – At 46.7% insider ownership, management is heavily aligned with shareholder interests.
Massive Market Tailwinds – Healthcare AI, clinical trials, digital health, and regulatory trends all converge here.
Recurring Revenue Model – Enterprise data licensing provides predictability and scalability.
Positive Momentum – Trading above both its 50-day ($0.52) and 200-day ($0.72) moving averages, suggesting technical strength.
Recent Insider Buying.
When combined, these factors position ONMD as a potential “under-the-radar” healthcare data play with asymmetric upside.
Chart: Trading above moving averages, looking for a golden cross in the near-term.
Take a minute to view this must-read full report and disclosures on ONMD: https://bestgrowthstocks.com/onemednet-nasdaq...ealthcare/
It’s not biotech. It’s not big pharma. It’s the infrastructure behind both—and that could make all the difference!
(0)
(0)
